Article metrics

Download PDFPDF

A Phase I, open-label, dose escalation study of MGA271 in combination with ipilimumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck or non-small cell lung cancer
Free

 

Online download statistics by month:

Online download statistics by month: January 2020 to January 2024

AbstractFullPdf
Jan 2020020
Feb 2020010
Mar 2020020
Apr 2020020
May 2020080
Jun 20200210
Jul 2020010
Aug 2020042
Sep 2020050
Oct 2020020
Nov 2020030
Dec 2020010
Jan 2021041
Feb 2021041
Mar 2021021
Apr 2021050
Jun 2021050
Jul 2021040
Aug 2021065
Sep 2021010
Oct 2021030
Nov 2021071
Dec 2021080
Jan 2022050
Feb 2022031
Mar 2022063
Apr 2022071
May 20220102
Jun 2022083
Jul 2022092
Aug 20220111
Sep 2022052
Oct 2022093
Nov 2022092
Dec 2022071
Jan 2023041
Feb 2023061
Mar 2023065
Apr 2023049
May 2023034
Jun 20230101
Jul 2023012
Aug 2023053
Sep 20230101
Oct 2023094
Nov 20230192
Dec 20230122
Jan 2024020
Total028167